AwesomeCapital
Thursday, April 30, 2020
Clinical trial launched testing convalescent plasma in COVID-19
›
Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have initiated a clinical trial evaluating the efficacy of ...
Lockdown panic syndrome, and how to fix it
›
The worldwide pandemic over COVID-19, and the heavy-handed government response to it, has generated a wide range of reaction among patients...
Remdesivir results pile up, but what do they all mean?
›
The latest addition to remdesivir’s Covid-19 dataset paints a confusing picture, but it’s not necessarily bad. In a market desper...
BofA cautions on Teladoc on potential competitive encroachment
›
In a note, Bank of America analyst Allen Lutz (Neutral/$194) warns clients that Teladoc’s ( TDOC -6.2% ) potential reach in the academic ...
Aveo Pharma up 40% after business update
›
AVEO Pharmaceuticals ( AVEO +40.2% ), fresh off a volatility halt, is up on a 15x surge in volume after its business update today. Key p...
Gilead to be challenged to meet demand for remdesivir
›
Gilead Sciences ( GILD +0.9% ) will be hustling to produce sufficient quantities of antiviral remdesivir after the expected nod from regu...
Retracted Study Claimed Broader Spread of Aerosolized Coronavirus
›
A study which found that aerosolized novel coronavirus could be spread nearly 15 feet — twice what health officials had believed — has bee...
‹
›
Home
View web version